Kaye Edward M. MD

Insider

Director

Trades at: STOK· CYTK· RNA

30D 90D 1Y

Net shares · 365d

-228.4K

0 buy · 228.4K sell

Net value · 365d

-$7.8M

$0 in · $7.8M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 228.4K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

STOK Grant·A
Jun 3, 26

Director

$0

17.8K sh

Own New
CYTK Sell·S
Jun 1, 26

Director · 10b5-1

$223.2K

2.9K sh · $76.09

Own -22%
CYTK Grant·A
May 27, 26

Director

$0

4.3K sh

Own New
CYTK Grant·A
May 27, 26

Director

$0

2.9K sh

Own +28%
CYTK Grant·A
Apr 15, 26

Director

$12.5K

191 sh · $65.37

Own +2%
STOK Exercise·M
Mar 15, 26

Director

$0

61.8K sh · 2 lots

Own New
STOK Exercise·M
Mar 15, 26

Director

$0

61.8K sh · 2 lots

Own +126%
RNA Other·D
Feb 27, 26

Director

—

103.4K sh · 7 lots

Own -100%
RNA Other·D
Feb 27, 26

Director

—

6.7K sh

Own -100%
CYTK Grant·A
Jan 15, 26

Director

$12.5K

197 sh · $63.44

Own +2%
STOK Sell·S
Dec 8, 25

Director · 10b5-1

$433.4K

13.4K sh · $32.27 avg · 3 lots

Own -21%
STOK Sell·S
Dec 5, 25

Director · 10b5-1

$466.9K

15.0K sh · $31.13 avg · 5 lots

Own -19%
STOK Sell·S
Dec 3, 25

Director

$64.5K

2.1K sh · $30.22 avg · 4 lots

Own -4%
STOK Exercise·M
Dec 3, 25

Director · 10b5-1

$0

26.2K sh

Own New
STOK Exercise·M
Dec 3, 25

Director · 10b5-1

$0

26.2K sh

Own +51%
CYTK Exercise·M
Dec 1, 25

Director · 10b5-1

$0

28.1K sh · 2 lots

Own New
CYTK Sell·S
Dec 1, 25

Director · 10b5-1

$1.9M

28.1K sh · $66.72

Own -74%
CYTK Exercise·M
Dec 1, 25

Director · 10b5-1

$385.0K

28.1K sh · $13.72 avg · 2 lots

Own New
STOK Exercise·M
Dec 1, 25

Director

$0

4.3K sh

Own New
CYTK Exercise·M
Nov 11, 25

Director · 10b5-1

$0

5.2K sh

Own New
CYTK Exercise·M
Nov 11, 25

Director · 10b5-1

$50.0K

5.2K sh · $9.66

Own +52%
CYTK Sell·S
Nov 11, 25

Director · 10b5-1

$336.8K

5.2K sh · $65.08

Own -34%
CYTK Grant·A
Oct 15, 25

Director

$12.5K

199 sh · $62.80

Own +2%
STOK Exercise·M
Oct 8, 25

Director · 10b5-1

$0

25.0K sh

Own +5%
STOK Exercise·M
Oct 8, 25

Director · 10b5-1

$15.0K

25.0K sh · $0.60

Own +51%
STOK Sell·S
Oct 8, 25

Director · 10b5-1

$750.0K

25.0K sh · $30.00

Own -34%
CYTK Sell·S
Oct 6, 25

Director · 10b5-1

$405.4K

6.8K sh · $60.00

Own -41%
STOK Sell·S
Oct 3, 25

Director · 10b5-1

$1.1M

42.5K sh · $25.09

Own -46%
CYTK Sell·S
Sep 30, 25

Director · 10b5-1

$368.8K

6.7K sh · $55.08

Own -29%
STOK Other·D
Sep 4, 25

Director

$0

322.5K sh · 2 lots

Own -100%
STOK Sell·S
Sep 3, 25

Director · 10b5-1

$1.2M

61.9K sh · $20.13 avg · 3 lots

Own -40%
CYTK Sell·S
Sep 2, 25

Director · 10b5-1

$337.8K

6.8K sh · $50.00

Own -23%
STOK Sell·S
Aug 18, 25

Director

$221.2K

12.1K sh · $18.24

Own -7%
STOK Exercise·M
Aug 14, 25

Director

$0

26.2K sh

Own New
STOK Grant·A
Aug 14, 25

Director

$0

52.5K sh

Own New
STOK Exercise·M
Aug 14, 25

Director

$0

26.2K sh

Own +19%
CYTK Grant·A
Jul 15, 25

Director

$12.5K

328 sh · $38.01

Own +1%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 3, 2026	STOK	Director	Grant A	17.8K	New	—	$0
Jun 1, 2026	CYTK	Director	Sell S	2.9K	-22%	$76.09	$223.2K
May 27, 2026	CYTK	Director	Grant A	4.3K	New	—	$0
May 27, 2026	CYTK	Director	Grant A	2.9K	+28%	—	$0
Apr 15, 2026	CYTK	Director	Grant A	191	+2%	$65.37	$12.5K
Mar 15, 2026	STOK	Director	Exercise M	61.8K2 lots	New	—	$0
Mar 15, 2026	STOK	Director	Exercise M	61.8K2 lots	+126%	—	$0
Feb 27, 2026	RNA	Director	Other D	103.4K7 lots	-100%	—	—
Feb 27, 2026	RNA	Director	Other D	6.7K	-100%	—	—
Jan 15, 2026	CYTK	Director	Grant A	197	+2%	$63.44	$12.5K
Dec 8, 2025	STOK	Director	Sell S	13.4K3 lots	-21%	$32.27 avg	$433.4K
Dec 5, 2025	STOK	Director	Sell S	15.0K5 lots	-19%	$31.13 avg	$466.9K
Dec 3, 2025	STOK	Director	Sell S	2.1K4 lots	-4%	$30.22 avg	$64.5K
Dec 3, 2025	STOK	Director	Exercise M	26.2K	New	—	$0
Dec 3, 2025	STOK	Director	Exercise M	26.2K	+51%	—	$0
Dec 1, 2025	CYTK	Director	Exercise M	28.1K2 lots	New	—	$0
Dec 1, 2025	CYTK	Director	Sell S	28.1K	-74%	$66.72	$1.9M
Dec 1, 2025	CYTK	Director	Exercise M	28.1K2 lots	New	$13.72 avg	$385.0K
Dec 1, 2025	STOK	Director	Exercise M	4.3K	New	—	$0
Nov 11, 2025	CYTK	Director	Exercise M	5.2K	New	—	$0
Nov 11, 2025	CYTK	Director	Exercise M	5.2K	+52%	$9.66	$50.0K
Nov 11, 2025	CYTK	Director	Sell S	5.2K	-34%	$65.08	$336.8K
Oct 15, 2025	CYTK	Director	Grant A	199	+2%	$62.80	$12.5K
Oct 8, 2025	STOK	Director	Exercise M	25.0K	+5%	—	$0
Oct 8, 2025	STOK	Director	Exercise M	25.0K	+51%	$0.60	$15.0K
Oct 8, 2025	STOK	Director	Sell S	25.0K	-34%	$30.00	$750.0K
Oct 6, 2025	CYTK	Director	Sell S	6.8K	-41%	$60.00	$405.4K
Oct 3, 2025	STOK	Director	Sell S	42.5K	-46%	$25.09	$1.1M
Sep 30, 2025	CYTK	Director	Sell S	6.7K	-29%	$55.08	$368.8K
Sep 4, 2025	STOK	Director	Other D	322.5K2 lots	-100%	—	$0
Sep 3, 2025	STOK	Director	Sell S	61.9K3 lots	-40%	$20.13 avg	$1.2M
Sep 2, 2025	CYTK	Director	Sell S	6.8K	-23%	$50.00	$337.8K
Aug 18, 2025	STOK	Director	Sell S	12.1K	-7%	$18.24	$221.2K
Aug 14, 2025	STOK	Director	Exercise M	26.2K	New	—	$0
Aug 14, 2025	STOK	Director	Grant A	52.5K	New	—	$0
Aug 14, 2025	STOK	Director	Exercise M	26.2K	+19%	—	$0
Jul 15, 2025	CYTK	Director	Grant A	328	+1%	$38.01	$12.5K

Buy Sell Non-market (grant · exercise · gift)

About Kaye Edward M. MD

This profile aggregates every SEC Form 4 insider transaction reported by Kaye Edward M. MD across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.